The Valley Desk

NCT00132522 · Interventional trial

EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide

Overall registry status Completed

Phase 1

Conditions Carcinoma, Non-small-cell Lung, Colorectal Cancer, Ovarian Cancer, Prostate Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov